SVRA
Savara Inc.
Price Chart
Latest Quote
$4.86
+0.34 (+7.52%)
Current Price
| Previous Close | $4.52 |
| Open | $4.49 |
| Day High | $4.91 |
| Day Low | $4.45 |
| Volume | 3,590,010 |
Stock Information
| Shares Outstanding | 205.46M |
| Total Debt | $30.41M |
| Cash Equivalents | $174.82M |
| Net Income | $-139.31M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $998.54M |
| EPS (TTM) | $-0.58 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.00B |
| Income | $-139.31M |
| Book/sh | $0.56 |
| Cash/sh | $0.85 |
| Employees | 70 |
Financial Ratios
| Quick Ratio | 9.99 |
| Current Ratio | 10.13 |
| Debt/Eq | 21.17 |
Returns & Margins
| ROA | -50.14% |
| ROE | -105.48% |
Ownership
| Insider Ownership | 2.55% |
| Institutional Ownership | 106.82% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -13.24 |
| P/B | 8.60 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $11.06 |
Technical Indicators
| SMA20 | $4.74 |
| SMA50 | $5.11 |
| SMA200 | $5.41 |
| RSI | 49.52 |
| ATR | 0.2885 |
| Shares Float | 129.75M |
| Short Float | 24.78% |
| Short Ratio | 22.78 |
| Volatility | 0.20 |
| Rel Volume | 1.30 |
Performance History
| Week | +2.10% |
| Month | -4.14% |
| Quarter | -7.95% |
| 6 Months | -3.19% |
| YTD | -13.83% |
| Year | +11.47% |
| 3 Years | +50.00% |
| 5 Years | +285.71% |
| 10 Years | -44.52% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $4.86 | 3,590,010 |
| 2026-10-26 | $4.52 | 3,445,100 |
| 2026-10-23 | $4.22 | 2,827,900 |
| 2026-10-22 | $4.54 | 2,709,700 |
| 2026-10-21 | $4.67 | 2,086,100 |
| 2026-10-20 | $4.76 | 4,417,400 |
| 2026-10-19 | $4.63 | 1,560,300 |
| 2026-10-16 | $4.45 | 2,235,000 |
| 2026-10-15 | $4.74 | 1,690,900 |
| 2026-10-14 | $4.76 | 2,574,300 |
| 2026-10-13 | $4.78 | 3,742,100 |
| 2026-10-12 | $4.84 | 1,306,700 |
| 2026-10-09 | $4.92 | 1,529,100 |
| 2026-10-08 | $4.83 | 2,514,600 |
| 2026-10-07 | $4.88 | 2,414,900 |
| 2026-10-06 | $4.65 | 2,289,400 |
| 2026-10-05 | $4.78 | 2,862,300 |
| 2026-10-02 | $4.81 | 2,653,300 |
| 2026-10-01 | $5.05 | 2,549,600 |
| 2026-09-30 | $5.16 | 6,051,300 |
| 2026-09-29 | $5.08 | 2,034,700 |
| 2026-09-28 | $5.07 | 4,371,000 |
About Savara Inc.
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.
đ° Latest News
No news articles available at the moment. Check back later for updates on SVRA.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $122,763,000 | $102,399,000 | $59,210,000 | $38,043,000 |
| Other Income Expense | $-236,000 | $51,000 | $76,000 | $-19,000 |
| Net Non Operating Interest Income Expense | $4,162,000 | $6,467,000 | $4,436,000 | $-88,000 |
| Operating Expense | $122,763,000 | $102,399,000 | $59,210,000 | $38,043,000 |
| General And Administrative Expense | $42,056,000 | $25,037,000 | $15,668,000 | $10,929,000 |
| Total Other Finance Cost | - | - | $-4,436,000 | $88,000 |
| Interest Expense | - | - | - | $88,000 |
| Interest Expense Non Operating | - | - | - | $88,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-118,837,000 | $-95,881,000 | $-54,698,000 | $-38,150,000 |
| Net Interest Income | $4,162,000 | $6,467,000 | $4,436,000 | $-88,000 |
| Interest Income | $4,162,000 | $6,467,000 | $4,436,000 | - |
| Normalized Income | $-118,601,000 | $-95,932,000 | $-54,774,000 | $-38,131,000 |
| Net Income From Continuing And Discontinued Operation | $-118,837,000 | $-95,881,000 | $-54,698,000 | $-38,150,000 |
| Total Operating Income As Reported | $-123,547,000 | $-103,196,000 | $-60,007,000 | $-38,839,000 |
| Net Income Common Stockholders | $-118,837,000 | $-95,881,000 | $-54,698,000 | $-38,150,000 |
| Net Income | $-118,837,000 | $-95,881,000 | $-54,698,000 | $-38,150,000 |
| Net Income Including Noncontrolling Interests | $-118,837,000 | $-95,881,000 | $-54,698,000 | $-38,150,000 |
| Net Income Continuous Operations | $-118,837,000 | $-95,881,000 | $-54,698,000 | $-38,150,000 |
| Pretax Income | $-118,837,000 | $-95,881,000 | $-54,698,000 | $-38,150,000 |
| Special Income Charges | $-546,000 | $0 | - | - |
| Interest Income Non Operating | $4,162,000 | $6,467,000 | $4,436,000 | - |
| Operating Income | $-122,763,000 | $-102,399,000 | $-59,210,000 | $-38,043,000 |
| Depreciation Amortization Depletion Income Statement | $87,000 | $130,000 | $77,000 | $31,000 |
| Depreciation And Amortization In Income Statement | $87,000 | $130,000 | $77,000 | $31,000 |
| Per Share | ||||
| Diluted EPS | $-0.53 | $-0.48 | $-0.33 | $-0.25 |
| Basic EPS | $-0.53 | $-0.48 | $-0.33 | $-0.25 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-122,440,000 | $-102,320,000 | $-59,209,000 | $-37,857,000 |
| Total Unusual Items | $-236,000 | $51,000 | $76,000 | $-19,000 |
| Total Unusual Items Excluding Goodwill | $-236,000 | $51,000 | $76,000 | $-19,000 |
| Reconciled Depreciation | $87,000 | $130,000 | $77,000 | $167,000 |
| EBITDA (Bullshit earnings) | $-122,676,000 | $-102,269,000 | $-59,133,000 | $-37,876,000 |
| EBIT | $-122,763,000 | $-102,399,000 | $-59,210,000 | $-38,043,000 |
| Diluted Average Shares | $222,387,531 | $198,191,936 | $165,204,652 | $152,771,817 |
| Basic Average Shares | $222,387,531 | $198,191,936 | $165,204,652 | $152,771,817 |
| Diluted NI Availto Com Stockholders | $-118,837,000 | $-95,881,000 | $-54,698,000 | $-38,150,000 |
| Other Special Charges | $546,000 | - | - | - |
| Gain On Sale Of Security | $310,000 | $51,000 | $76,000 | $-19,000 |
| Other Taxes | $-784,000 | $-797,000 | $-797,000 | $-796,000 |
| Research And Development | $81,404,000 | $78,029,000 | $44,262,000 | $27,879,000 |
| Selling General And Administration | $42,056,000 | $25,037,000 | $15,668,000 | $10,929,000 |
| Other Gand A | $42,056,000 | $25,037,000 | $15,668,000 | $10,929,000 |
Fetched: 2026-10-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $191,497,000 | $161,112,000 | $129,412,000 | $97,122,000 |
| Total Assets | $253,436,000 | $212,879,000 | $177,564,000 | $139,777,000 |
| Total Non Current Assets | $11,820,000 | $10,744,000 | $11,617,000 | $10,823,000 |
| Other Non Current Assets | $84,000 | $242,000 | $387,000 | $116,000 |
| Other Intangible Assets | $11,636,000 | $10,337,000 | $10,960,000 | $10,656,000 |
| Current Assets | $241,616,000 | $202,135,000 | $165,947,000 | $128,954,000 |
| Other Current Assets | $892,000 | $455,000 | $280,000 | $71,000 |
| Hedging Assets Current | $394,000 | $0 | - | - |
| Prepaid Assets | $3,374,000 | $4,310,000 | $2,343,000 | $2,053,000 |
| Receivables | $1,254,000 | $1,043,000 | $1,005,000 | $954,000 |
| Taxes Receivable | $1,254,000 | $1,043,000 | $1,005,000 | $954,000 |
| Cash Cash Equivalents And Short Term Investments | $235,702,000 | $196,327,000 | $162,319,000 | $125,876,000 |
| Cash And Cash Equivalents | $33,180,000 | $15,128,000 | $26,585,000 | $52,100,000 |
| Debt | ||||
| Total Debt | $29,914,000 | $26,735,000 | $26,491,000 | $26,142,000 |
| Long Term Debt And Capital Lease Obligation | $29,907,000 | $26,619,000 | $26,348,000 | $26,078,000 |
| Long Term Debt | $29,907,000 | $26,619,000 | $26,348,000 | $26,078,000 |
| Current Debt And Capital Lease Obligation | $7,000 | $116,000 | $143,000 | $64,000 |
| Net Debt | - | $11,491,000 | - | - |
| Current Debt | - | - | - | - |
| Other Current Borrowings | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $50,303,000 | $41,430,000 | $37,192,000 | $31,999,000 |
| Total Non Current Liabilities Net Minority Interest | $29,907,000 | $26,706,000 | $26,595,000 | $26,132,000 |
| Current Liabilities | $20,396,000 | $14,724,000 | $10,597,000 | $5,867,000 |
| Other Current Liabilities | $362,000 | - | - | - |
| Payables And Accrued Expenses | $13,475,000 | $9,591,000 | $6,408,000 | $3,438,000 |
| Payables | $5,757,000 | $4,545,000 | $3,504,000 | $1,334,000 |
| Accounts Payable | $5,757,000 | $4,545,000 | $3,504,000 | $1,334,000 |
| Other Non Current Liabilities | - | $87,000 | $247,000 | $54,000 |
| Equity | ||||
| Common Stock Equity | $203,133,000 | $171,449,000 | $140,372,000 | $107,778,000 |
| Total Equity Gross Minority Interest | $203,133,000 | $171,449,000 | $140,372,000 | $107,778,000 |
| Stockholders Equity | $203,133,000 | $171,449,000 | $140,372,000 | $107,778,000 |
| Gains Losses Not Affecting Retained Earnings | $-87,000 | $-750,000 | $-271,000 | $-605,000 |
| Other Equity Adjustments | $-87,000 | $-750,000 | $-271,000 | $-605,000 |
| Retained Earnings | $-608,087,000 | $-489,250,000 | $-393,369,000 | $-338,671,000 |
| Other | ||||
| Ordinary Shares Number | $204,567,283 | $172,423,223 | $138,143,545 | $114,046,345 |
| Share Issued | $204,567,283 | $172,423,223 | $138,143,545 | $114,046,345 |
| Tangible Book Value | $191,497,000 | $161,112,000 | $129,412,000 | $97,122,000 |
| Invested Capital | $233,040,000 | $198,068,000 | $166,720,000 | $133,856,000 |
| Working Capital | $221,220,000 | $187,411,000 | $155,350,000 | $123,087,000 |
| Capital Lease Obligations | $7,000 | $116,000 | $143,000 | $64,000 |
| Total Capitalization | $233,040,000 | $198,068,000 | $166,720,000 | $133,856,000 |
| Additional Paid In Capital | $811,103,000 | $661,276,000 | $533,872,000 | $446,938,000 |
| Capital Stock | $204,000 | $173,000 | $140,000 | $116,000 |
| Common Stock | $204,000 | $173,000 | $140,000 | $116,000 |
| Current Capital Lease Obligation | $7,000 | $116,000 | $143,000 | $64,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $6,552,000 | $5,017,000 | $4,046,000 | $2,365,000 |
| Current Accrued Expenses | $7,718,000 | $5,046,000 | $2,904,000 | $2,104,000 |
| Net PPE | $100,000 | $165,000 | $270,000 | $51,000 |
| Accumulated Depreciation | $-2,333,000 | $-2,162,000 | $-2,012,000 | $-1,923,000 |
| Gross PPE | $2,433,000 | $2,327,000 | $2,282,000 | $1,974,000 |
| Leases | $333,000 | $333,000 | $333,000 | $145,000 |
| Other Properties | $1,980,000 | $1,874,000 | $1,839,000 | $1,768,000 |
| Machinery Furniture Equipment | $120,000 | $120,000 | $110,000 | $61,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $202,522,000 | $181,199,000 | $135,734,000 | $73,776,000 |
Fetched: 2026-10-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-101,059,000 | $-89,113,000 | $-51,357,000 | $-34,563,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-101,037,000 | $-89,088,000 | $-51,061,000 | $-34,554,000 |
| Cash Flow From Continuing Operating Activities | $-101,037,000 | $-89,088,000 | $-51,061,000 | $-34,554,000 |
| Operating Gains Losses | $704,000 | $145,000 | $22,000 | $19,000 |
| Investing Activities | ||||
| Capital Expenditure | $-22,000 | $-25,000 | $-296,000 | $-9,000 |
| Investing Cash Flow | $-18,440,000 | $-39,941,000 | $-57,116,000 | $52,645,000 |
| Cash Flow From Continuing Investing Activities | $-18,440,000 | $-39,941,000 | $-57,116,000 | $52,645,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-5,140,000 | $-995,000 | $-1,208,000 | $-3,000 |
| Issuance Of Capital Stock | $140,228,000 | $118,172,000 | $83,705,000 | $0 |
| Financing Cash Flow | $137,806,000 | $117,577,000 | $82,780,000 | $87,000 |
| Cash Flow From Continuing Financing Activities | $137,806,000 | $117,577,000 | $82,780,000 | $87,000 |
| Net Common Stock Issuance | $135,088,000 | $117,177,000 | $82,497,000 | $-3,000 |
| Common Stock Issuance | $140,228,000 | $118,172,000 | $83,705,000 | $0 |
| Net Other Financing Charges | - | $46,000 | - | - |
| Other | ||||
| Repayment Of Debt | $-27,229,000 | $0 | $0 | $-26,350,000 |
| Issuance Of Debt | $29,598,000 | $0 | $0 | $26,438,000 |
| Interest Paid Supplemental Data | $3,201,000 | $2,124,000 | $2,040,000 | $1,614,000 |
| End Cash Position | $33,180,000 | $15,128,000 | $26,585,000 | $52,100,000 |
| Beginning Cash Position | $15,128,000 | $26,585,000 | $52,100,000 | $34,012,000 |
| Effect Of Exchange Rate Changes | $-277,000 | $-5,000 | $-118,000 | $-90,000 |
| Changes In Cash | $18,329,000 | $-11,452,000 | $-25,397,000 | $18,178,000 |
| Proceeds From Stock Option Exercised | $349,000 | $354,000 | $283,000 | $2,000 |
| Common Stock Payments | $-5,140,000 | $-995,000 | $-1,208,000 | $-3,000 |
| Net Issuance Payments Of Debt | $2,369,000 | $0 | $0 | $88,000 |
| Net Long Term Debt Issuance | $2,369,000 | $0 | $0 | $88,000 |
| Long Term Debt Payments | $-27,229,000 | $0 | $0 | $-26,350,000 |
| Long Term Debt Issuance | $29,598,000 | $0 | $0 | $26,438,000 |
| Net Investment Purchase And Sale | $-18,418,000 | $-39,916,000 | $-56,820,000 | $52,654,000 |
| Sale Of Investment | $186,481,000 | $165,000,000 | $137,400,000 | $142,069,000 |
| Purchase Of Investment | $-204,899,000 | $-204,916,000 | $-194,220,000 | $-89,415,000 |
| Net PPE Purchase And Sale | $-22,000 | $-25,000 | $-296,000 | $-9,000 |
| Purchase Of PPE | $-22,000 | $-25,000 | $-296,000 | $-9,000 |
| Change In Working Capital | $5,001,000 | $1,829,000 | $4,073,000 | $960,000 |
| Change In Other Current Assets | $98,000 | $11,000 | $-12,000 | $-57,000 |
| Change In Payables And Accrued Expense | $4,806,000 | $4,201,000 | $4,541,000 | $-319,000 |
| Change In Payable | $4,806,000 | $4,201,000 | $4,541,000 | $-319,000 |
| Change In Account Payable | $4,806,000 | $4,201,000 | $4,541,000 | $-319,000 |
| Change In Prepaid Assets | $97,000 | $-2,383,000 | $-456,000 | $1,336,000 |
| Other Non Cash Items | $453,000 | $271,000 | $271,000 | $334,000 |
| Stock Based Compensation | $14,421,000 | $9,860,000 | $4,178,000 | $2,041,000 |
| Amortization Of Securities | $-2,866,000 | $-5,442,000 | $-4,984,000 | $75,000 |
| Depreciation Amortization Depletion | $87,000 | $130,000 | $77,000 | $167,000 |
| Depreciation And Amortization | $87,000 | $130,000 | $77,000 | $167,000 |
| Gain Loss On Sale Of PPE | $158,000 | $145,000 | $98,000 | - |
| Net Income From Continuing Operations | $-118,837,000 | $-95,881,000 | $-54,698,000 | $-38,150,000 |
| Net Foreign Currency Exchange Gain Loss | - | $0 | $-76,000 | $19,000 |
| Depreciation | - | - | $175,000 | $167,000 |
| Change In Other Current Liabilities | - | - | - | $0 |
| Net Intangibles Purchase And Sale | - | - | - | - |
| Purchase Of Intangibles | - | - | - | - |
| Unrealized Gain Loss On Investment Securities | - | - | - | - |
Fetched: 2026-10-20